We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.31B
AUM Growth
-$186M
Cap. Flow
-$183M
Cap. Flow %
-3.46%
Top 10 Hldgs %
19.09%
Holding
839
New
96
Increased
271
Reduced
217
Closed
105

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$58.6M
2
BIIB icon
Biogen
BIIB
+$40.7M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$29.8M
4
BIDU icon
Baidu
BIDU
+$27.4M
5
AAPL icon
Apple
AAPL
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 14.94%
2 Industrials 14.89%
3 Financials 13.29%
4 Energy 11.49%
5 Consumer Discretionary 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEC icon
226
WEC Energy
WEC
$37.7B
$1.53M 0.03%
35,637
-596
-2% -$26.5K
UNF icon
227
Unifirst Corp
UNF
$5.32B
$1.5M 0.03%
15,583
AEK.CL
228
DELISTED
Aegon NV
AEK.CL
$1.5M 0.03%
52,566
-100
-0.2% -$2.87K
TW
229
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$1.47M 0.03%
14,797
-3,279
-18% -$346K
PANW icon
230
Palo Alto Networks
PANW
$264B
$1.47M 0.03%
89,610
+960
+1% +$13.8K
FAST icon
231
Fastenal
FAST
$54B
$1.46M 0.03%
130,360
-22,928
-15% -$262K
MRK icon
232
Merck
MRK
$324B
$1.46M 0.03%
25,739
+510
+2% +$28.6K
NORD
233
DELISTED
Nord Anglia Education, Inc.
NORD
$1.44M 0.03%
84,617
-2,690
-3% -$50.5K
BLK icon
234
Blackrock
BLK
$164B
$1.42M 0.03%
4,337
-76
-2% -$24.5K
NGHCP
235
DELISTED
National General Holdings Corp Preferred Stock, Series A
NGHCP
$1.4M 0.03%
56,750
+7,050
+14% +$177K
UAA icon
236
Under Armour
UAA
$3B
$1.39M 0.03%
40,473
+32,428
+403% +$1.07M
DE icon
237
Deere & Co
DE
$170B
$1.39M 0.03%
16,916
-968
-5% -$82.8K
QQQ icon
238
Invesco QQQ Trust
QQQ
$455B
$1.36M 0.03%
13,769
-353
-2% -$34.4K
LKQ icon
239
LKQ Corp
LKQ
$6.58B
$1.36M 0.03%
50,980
-2,530
-5% -$68.1K
APC
240
DELISTED
Anadarko Petroleum
APC
$1.35M 0.03%
13,281
-2,571
-16% -$277K
DEO icon
241
Diageo
DEO
$46.2B
$1.34M 0.03%
11,635
+15
+0.1% +$1.82K
TS icon
242
Tenaris
TS
$29.1B
$1.34M 0.03%
29,495
+10,000
+51% +$449K
USB icon
243
US Bancorp
USB
$99.6B
$1.33M 0.03%
31,889
+953
+3% +$40.3K
JEF icon
244
Jefferies Financial Group
JEF
$12.9B
$1.31M 0.02%
61,567
-5,565
-8% -$125K
VTI icon
245
Vanguard Total Stock Market ETF
VTI
$654B
$1.31M 0.02%
12,930
-463
-3% -$47.3K
CTRA
246
DELISTED
Coterra Energy
CTRA
$1.3M 0.02%
39,739
-552
-1% -$18.5K
ANDX
247
DELISTED
Andeavor Logistics LP
ANDX
$1.28M 0.02%
18,040
+590
+3% +$41.4K
VFC icon
248
VF Corp
VFC
$6.68B
$1.27M 0.02%
20,448
-875
-4% -$52.3K
ARCC icon
249
Ares Capital
ARCC
$13.5B
$1.25M 0.02%
77,605
-9,825
-11% -$166K
EMR icon
250
Emerson Electric
EMR
$82.9B
$1.25M 0.02%
20,020
-629
-3% -$40.8K

Similar funds

Geneva Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Geneva Advisors held 839 positions worth $5.31B, down 3.4% from $5.49B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneva Advisors withdrew a net $183M in Q3 2014, closing 105 positions and reducing 217 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $24.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.

Against the trend, Geneva Advisors opened a new position in Discovery, Inc. Series C Common Stock worth $27.5M.

  • Geneva Advisors's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 736,897 shares worth $27.5M.
  • Geneva Advisors added most to AbbVie in Q3 2014, an estimated $58.6M increase.
  • Geneva Advisors's biggest Q3 2014 reduction was Warner Bros, cutting an estimated $62.3M.
  • Geneva Advisors fully exited ASPEN TECHNOLOGY INC in Q3 2014, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 19% of its $5.31B portfolio in Q3 2014.
  • Geneva Advisors opened 96 new positions and closed 105 in Q3 2014.
  • Geneva Advisors's portfolio value fell 3.4% quarter-over-quarter to $5.31B.

Based on Geneva Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.